Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 2 |
2016 | 1 |
2017 | 1 |
2018 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology.
Cancers (Basel). 2022 Jul 19;14(14):3509. doi: 10.3390/cancers14143509.
Cancers (Basel). 2022.
PMID: 35884568
Free PMC article.
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story.
García-Cano J, Roche O, Cimas FJ, Pascual-Serra R, Ortega-Muelas M, Fernández-Aroca DM, Sánchez-Prieto R.
García-Cano J, et al. Among authors: pascual serra r.
Front Cell Dev Biol. 2016 Jun 30;4:69. doi: 10.3389/fcell.2016.00069. eCollection 2016.
Front Cell Dev Biol. 2016.
PMID: 27446920
Free PMC article.
Review.
Item in Clipboard
E1a is an exogenous in vivo tumour suppressor.
Cimas FJ, Callejas-Valera JL, García-Olmo DC, Hernández-Losa J, Melgar-Rojas P, Ruiz-Hidalgo MJ, Pascual-Serra R, Ortega-Muelas M, Roche O, Marcos P, Garcia-Gil E, Fernandez-Aroca DM, Ramón Y Cajal S, Gutkind JS, Sanchez-Prieto R.
Cimas FJ, et al. Among authors: pascual serra r.
Cancer Lett. 2017 Jul 28;399:74-81. doi: 10.1016/j.canlet.2017.04.010. Epub 2017 Apr 15.
Cancer Lett. 2017.
PMID: 28416454
Item in Clipboard
ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology.
Ortega-Muelas M, Roche O, Fernández-Aroca DM, Encinar JA, Albandea-Rodríguez D, Arconada-Luque E, Pascual-Serra R, Muñoz I, Sánchez-Pérez I, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R.
Ortega-Muelas M, et al. Among authors: pascual serra r.
J Cell Mol Med. 2021 Nov;25(22):10591-10603. doi: 10.1111/jcmm.16990. Epub 2021 Oct 16.
J Cell Mol Med. 2021.
PMID: 34655447
Free PMC article.
Item in Clipboard
Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.
García-Cano J, Ambroise G, Pascual-Serra R, Carrión MC, Serrano-Oviedo L, Ortega-Muelas M, Cimas FJ, Sabater S, Ruiz-Hidalgo MJ, Sanchez Perez I, Mas A, Jalón FA, Vazquez A, Sánchez-Prieto R.
García-Cano J, et al. Among authors: pascual serra r.
Oncotarget. 2015 Jun 20;6(17):15551-65. doi: 10.18632/oncotarget.3902.
Oncotarget. 2015.
PMID: 26036632
Free PMC article.
Item in Clipboard
Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion.
Serrano-Oviedo L, Ortega-Muelas M, García-Cano J, Valero ML, Cimas FJ, Pascual-Serra R, Fernandez-Aroca DM, Roche O, Ruiz-Hidalgo MJ, Belandia B, Giménez-Bachs JM, Salinas AS, Sanchez-Prieto R.
Serrano-Oviedo L, et al. Among authors: pascual serra r.
PLoS One. 2018 Jul 26;13(7):e0200878. doi: 10.1371/journal.pone.0200878. eCollection 2018.
PLoS One. 2018.
PMID: 30048489
Free PMC article.
Item in Clipboard
MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.
Cimas FJ, Callejas-Valera JL, Pascual-Serra R, García-Cano J, Garcia-Gil E, De la Cruz-Morcillo MA, Ortega-Muelas M, Serrano-Oviedo L, Gutkind JS, Sánchez-Prieto R.
Cimas FJ, et al. Among authors: pascual serra r.
Oncotarget. 2015 Dec 29;6(42):44095-107. doi: 10.18632/oncotarget.6574.
Oncotarget. 2015.
PMID: 26689986
Free PMC article.
Item in Clipboard
Cite
Cite